INTRODUCTION
Mammalian cells communicate with each other to control their proliferation, differentiation, survival and death (1) . Intercellular communication occurs through secreted ligands (cytokines, chemokines, growth factors and hormones), extracellular vesicles (exosomes and ectosomes) and direct physical contacts (gap junctions and cellular synapses) (2, 3) . Cell-to-cell communication also occurs via long, thin membrane extensions called cytonemes in Drosophila and tunneling nanotubes (TNTs), membrane nanotubes (MNTs) and long-distance filopodia in vertebrate (4) . TNTs have also been found open-or close-ended structures in rat pheochromocytoma PC12 cells, Raw264.7 cells and Jurkat T cells (5) (6) (7) .
TNTs intercellularly transfer mitochondria as well as small vesicles from the endoplasmic reticulum, Golgi complexes, and the early endosomes (8) . TNTs also transfer various pathological molecules, such as amyloid  peptides, Tau, prion, and -synuclein, disseminating these molecules into the surrounding cells (9) (10) (11) . Murine leukemia virus (MLV), influenza virus and herpes viruses also utilize TNTs to increase their dissemination efficiency (12) (13) (14) . TNTs generated by human immunodeficiency virus (HIV) infection in macrophages are necessary for the efficient cell-to-cell dissemination of HIV viruses (15) . In addition, human monocyte-derived macrophages utilize TNTs to trap and pull Mycobacterium bovis toward macrophage cell bodies (16) .
Because mycoplasma without a cell wall is resistant to antibiotics, such as penicillin, which inhibits bacterial cell wall synthesis, mycoplasma often contaminates mammalian cell cultures. Mycoplasma infection changes cellular metabolism and growth, destroying mammalian cell lines (17) . Several mycoplasma species are pathogenic in livestock and humans. Mycoplasma hyorhinis is a major cell culture contaminant that is often found in the swine respiratory tract and human skin (18) . Mycoplasma adheres to the outside of the host cell membrane, invades host cells and survives in intracellular vesicles in the host cells, avoiding immunological surveillance (19) . For example, Mycoplasma fermentans and Mycoplasma hominis are found in the vacuolar membrane of HeLa cells, which is the proliferation site of mycoplasma (20, 21) .
In 
RESULTS

Mycoplasma hyorhinis infection induced TNT formation
Although various mammalian cells have been known to possess TNTs, TNTs were not observed in various cell lines, such as NIH3T murine fibroblasts, CCD986-sk human fibroblasts, Huh7 human hepatocarcinomas and B16F10 murine melanomas, by differential interference contrast (DIC) microscopy ( Supplementary Fig. 1A , left panels). However, TNTs were observed in the extracellular space of these live cell lines after infection with Mycoplasma hyorhinis (M. hyorhinis) for 7 days ( Supplementary Fig. 1A , middle panels). After the M. hyorhinis infection, TNTs were found in most NIH3T3 cells, and each cell produced three or more TNTs; the other cell lines had results similar to those observed in NIH3T3 cells ( Supplementary Fig. 1B ). The TNTs disappeared from the M. hyorhinis-infected cell lines in the presence of mycoplasma removal agents (MRA) that specifically inhibit mycoplasma DNA gyrase ( Supplementary Fig. 1 ). Thus, we conclude that M. hyorhinis infection induces TNT formation in various mammalian cell lines.
Subsequently, we determined the intracellular or extracellular location of mycoplasmas from M. hyorhinis-infected NIH3T3 cells by immunofluorescence staining of the P70 protein, which is a cell surface antigen of M. hyorhinis. In the presence of gentamicin, which kills only extracellular mycoplasmas without affecting intracellular mycoplasmas because of its limited penetration into mammalian cells (20) , the P70 antigen disappeared from the non-permeabilized NIH3T3 cells but not from the permeabilized cells ( Supplementary Fig. 2 ), indicating that M. hyorhinis adheres to the host cell surface and invades host cells. To determine whether extracellular or intracellular M. hyorhinis induces TNT formation in NIH3T3 cells, we observed TNTs in the gentamicin-treated cells. As shown in Fig. 1A , M. hyorhinis-induced TNT formation was not altered by the gentamicin treatment, whereas TNT formation was inhibited by MRA, which kills both extracellular and intracellular mycoplasmas (Fig. 1B) . Thus, we conclude that intracellular M. hyorhinis induces TNT formation.
M. hyorhinis is localized in TNTs
To more clearly observe the TNTs in the extracellular space of the NIH3T3 cells after the M. hyorhinis infection, M. hyorhinis-free and -infected cells were stained with CellMast TM , which is a specific tracker of the plasma membrane. TNTs were observed after the M. hyorhinis infection in the live state. However, the TNTs disappeared after the paraformaldehyde fixation and permeabilization induced by Triton X-100 ( Supplementary Fig. 3A ), indicating that M. hyorhinis-induced TNTs are very vulnerable to fixation and permeabilization. Thus, M. hyorhinis-induced TNTs were always observed only in live cells in further experiments.
Because DAPI (4',6-diamidino-2-phenylindole) is permeable to cell membranes and has been used as a gold standard to detect intracellular mycoplasmas (18), we stained M. hyorhinis-infected NIH3T3 cells with DAPI. For DAPI staining of nucleus, cells are usually fixed and permeabilized and stained with DAPI at a very low concentration (300 nM) ( Supplementary Fig. 3B ). But the nuclei are hardly stained even at high concentrations (3 M) in live cells after 10 minutes. In contrast, infected mycoplasma in cells was stained with 3 M DAPI for 10 min (Fig. 1C) . In the P70 immunofluorescence after permeabilization ( Supplementary Fig. 3B ), the DAPI-stained small dots in the cytoplasm and near the plasma membrane were precisely co-localized with P70, even in the presence of gentamicin but not in the presence of MRA, indicating that DAPI could be useful for detecting intracellular M. hyorhinis. DAPI-stained dots were detected in TNTs and the cytoplasm of live NIH3T3 cells after M. hyorhinis infection with gentamicin but not with MRA (Fig. 1C) . These data indicate that DAPI staining is useful for detecting intracellular mycoplasma in live mammalian cells.
Mycoplasma transfers between NIH3T3 cells via TNTs
Because TNTs possess M. hyorhinis, TNTs might be necessary for the intercellular transfer of M. hyorhinis between mammalian cells. To test this possibility, EGFP-expressing NIH3T3 cells were infected with M. hyorhinis and used as mycoplasma donor cells, while tdTomato-expressing Chang http://bmbreports.org Liver cells were used as recipient cells. In the spatially separated co-culture system, the donor cells and recipient cells were cultured on the top and bottom plates and shared the same media ( Fig. 2A, left panel) . In the mixed co-culture system, the donor cells and recipient cells were co-cultured on the same plate to establish direct cell-to-cell contact between the donor and recipient cells (Fig. 2A, right panel) . Intracellular M. hyorhinis was monitored by DAPI staining in live cells. The tdTomato-expressing recipient cells in the mixed co-culture, but not the spatially separated co-culture, contained DAPIstained mycoplasmas (Fig. 2B) . In the mixed co-culture, DAPI-stained mycoplasmas were observed in TNTs between donor and recipient cells, indicating that M. hyorhinis disseminated from the donor cells to the recipient cells through TNTs (Fig. 2C) . The transfer of intracellular M. hyorhinis was also monitored by P70 immunoblotting. After the spatially separated co-culture or mixed co-culture, both the EGFP-expressing donor cells and tdTomato-expressing recipient cells were sorted by a fluorescence activated cell sorter (FACS) and analyzed by P70 immunoblotting. Fig. 2D shows that the tdTomato-recipient cells in the mixed cell co-culture, but not the spatially separated co-culture, possessed P70 antigen. These data indicate that M. hyorhinis-induced TNTs are required for the cell-to-cell dissemination of mycoplasmas.
M. hyorhinis infection induces TNT formation by Rac1 activation
Because mammalian TNTs are actin-and/or tubulin-based membrane protrusions, we monitored the TNTs after treating M. hyorhinis-infected NIH3T3 cells with cytochalasin B (an actin depolymerizer) or paclitaxel (a tubulin depolymerizer). The M. hyorhinis-induced TNTs disappeared after the treatment with cytochalasin B and paclitaxel (Fig. 3A) activity of RhoA (Fig. 3B) . Thus, we determined the effect of Rac1 activation on M. hyorhinis-induced TNT formation by treating M. hyorhinis-infected NIH3T3 cells with the Rac1-specific inhibitor NSC23766. The M. hyorhinis-induced TNTs disappeared after the treatment with NSC23766 (Fig.  3C) . To investigate whether NSC23766 affects the cell-to-cell dissemination of M. hyorhinis via TNTs, M. hyorhinis-infected donor EGFP cells were co-cultured with recipient tdTomato cells in the presence of NSC23766. In this mixed co-culture, NSC23766 decreased DAPI-stained M. hyorhinis in the recipient tdTomato cells (Fig. 3D) . In addition, the P70 immunoblotting showed that the NSC23766 treatment inhibited the presence of P70 antigen in the recipient tdTomato cells in the mixed co-culture system (Fig. 3E) . These data suggest that Rac1 activation is necessary for the M. hyorhinis-induced formation of TNTs and cell-to-cell dissemination through TNTs.
Genetic inhibition of Rac1 prevented the cell-to-cell dissemination of M. hyorhinis via TNTs
To investigate whether Rac1 activation is required for M. hyorhinis-induced TNT formation, TNTs were observed in M. hyorhinis-infected NIH3T3 cells after overexpressing EGFP-Rac1, EGFP-Rac1-Q61L (constitutively active form of Rac1, EGFP-CA-Rac1) and EGFP-Rac1-T17N (dominant negative form of Rac1, EGFP-DN-Rac1). The M. hyorhinis infection induced the localization of EGFP-Rac1 in TNTs in the EGFP-Rac1-overexpressing NIH3T3 cells (Fig. 4A) . The EGFP-CA-Rac1 overexpression induced TNT formation even without M. hyorhinis infection, whereas the EGFP-DN-Rac1 overexpression prevented M. hyorhinis-induced TNT formation (Fig. 4A) . These results indicate that Rac1 activation is essential for M. hyorhinis infection-induced TNT formation. Subsequently, we examined the effect of Rac1 activation on the cell-to-cell dissemination of mycoplasmas. The M. hyorhinis-infected donor cells were overexpressed using EGFP-Rac1, EGFP-CA-Rac1 or EGFP-DN-Rac1 and co-cultured with recipient tdTomato cells in a mixed cell culture system. DAPI-stained mycoplasma was found in the recipient tdTomato cells after the co-culture with the EGFP-Rac1 or EGFP-CA-Rac1 donor cells but not with the EGFP-DN-Rac1 donor cells (Fig. 4B, C) .
To further confirm that Rac1 is required for TNT formation, we monitored M. hyorhinis infection-induced TNT formation after Rac1 knockdown in NIH3T3 cells. Fig. 4D and E show that M. hyorhinis infection-induced TNT formation was inhibited by the Rac1 knockdown. Fig. 4F also shows that DAPI-stained dots were not observed in the recipient tdTomato cells co-cultured with the Rac1-knockdown donor EGFP cells in the mixed co-culture system (Fig. 4G) , suggesting that the cell-to-cell dissemination of M. hyorhinis from donor cells to recipient cells was prevented by the Rac1 knockdown in the donor cells. These data indicate that Rac1 is required for M. hyorhinis-induced TNT formation and cell-to cell dissemination of M. hyorhinis.
DISCUSSION
The dissemination of pathogens, such as viruses and bacteria, to surrounding host cells without leaving the host cells represents a powerful way of avoiding exposure to the host's immune system. Our data provide a novel mechanism of the cell-to-cell dissemination of M. hyorhinis through TNTs. The intracellular invasion of mycoplasma triggers Rac1 activation, leading to TNT formation in various mammalian cells. The TNTs were utilized as a novel intercellular pathway for the cell-to-cell dissemination of mycoplasma. Thus, the cell-to-cell dissemination of mycoplasma through TNTs can potentially overcome anti-bacterial innate immune defenses and the action of many antibiotics. Our data demonstrate that intracellular mycoplasmas survived in the presence of the antibiotic gentamicin and disseminated to surrounding host cells via TNTs.
Actin remodeling for TNT formation is regulated by the activation of small GTP binding proteins, such as RalA, Cdc42, RhoA and Rac1 (22) . For example, Cdc42 might be necessary for TNT formation because its knockdown and dominant negative form dramatically reduce the number of TNTs in HIV-1-infected dendritic cells and Fas-stimulated T lymphocytes (23, 24) . In contrast, the Cdc42/IRSp53/VASP network inhibited TNT production in neurons (25) . We also excluded the role of Cdc42 in M. hyorhinis infection-induced TNT formation because the M. hyorhinis infection decreased the activity of Cdc42 (Fig. 3A) . Instead of Cdc42, we focused on the role of Rac1 activation in M. hyorhinis infection-induced TNT formation because the activity of Rac1 was increased in M. hyorhinis-infected fibroblasts, and its pharmacological, knockdown and dominant negative form prevented M. hyorhinis infection-induced TNT formation (Fig. 3 and Fig. 4) . TNT formation is known to be induced by an actin-driven protrusion mechanism in which protrusions formed in one or both cells are connected or fused with the cell membrane of another cells (7) . The Rho family of GTPases such as Rac1 and CDC42 are involved in actin polymerization of these protrusions (22) . Mycoplasma-induced TNT had an actin-based structure similar to other pathogen-induced TNTs (Fig. 1A and  Fig. 3A) . The blocking of TNT formation by knockdown and dominant negative form of Rac1 ultimately results from the inhibition of actin polymerization in the protrusion. In RAW/LR5 macrophages, the Rac1-Arp2/3-WASP pathway is also required for TNT formation (26) . Several pathogens activate small GTP binding proteins in host cells to facilitate their proliferation. The gram-negative bacteria Shigella induces Cdc42 activation to increase bacterial invasion, and the Salmonella IpgB1 protein functions as a RhoA GTP binding protein to induce actin remodeling in host cells (27, 28) .
Mycoplasma is resistant to beta-lactam antibiotics (e.g., penicillin) because it lacks a cell wall; thus, macrolide, tetracycline, or fluoroquinolone classes have been used to treat mycoplasma-induced diseases, such as M. pneumoniaeinduced pneumonia. However, the emergence of macrolideresistant mycoplasma strains requires new treatments for mycoplasma-induced diseases (29) . Our data show that M. hyorhinis exploits TNTs for cell-to-cell dissemination. Although extracellular M. hyorhinis was removed by gentamicin in the infected cells, intracellular mycoplasmas were disseminated to surrounding cells via TNTs. Because the cell-to-cell dissemination of M. hyorhinis was prevented by the pharmacological or genetic inhibition of Rac1 (Fig. 3 and Fig.  4 ), Rac1 inhibition may be a novel strategy to alleviate mycoplasma-induced diseases.
MATERIALS AND METHODS
See Supplementary information.
